Devan
Devan Balachari, Boulder, CO US
Patent application number | Description | Published |
---|---|---|
20090136596 | P38 INHIBITORS AND METHODS OF USE THEREOF - This invention relates to inhibitors of p38 and methods of utilizing the inhibitors and pharmaceutical compositions thereof in the treatment and prevention of various disorders mediated by p38. | 05-28-2009 |
20090143422 | P38 INHIBITORS AND METHODS OF USE THEREOF - This invention relates to inhibitors of p38 and methods of utilizing the inhibitors and pharmaceutical compositions thereof in the treatment and prevention of various disorders mediated by p38. | 06-04-2009 |
20090149459 | P38 INHIBITORS AND METHODS OF USE THEREOF - This invention relates to inhibitors of p38 and methods of utilizing the inhibitors and pharmaceutical compositions thereof in the treatment and prevention of various disorders mediated by p38. | 06-11-2009 |
Devan Balachari, College Station, TX US
Patent application number | Description | Published |
---|---|---|
20120205540 | Ultra-High Densification of ZnS For Nano-Grain Optical Windows - A method is provided for producing an article which is transparent to infrared radiation. The method includes the steps of (a) disposing a plurality of nanoparticles on a substrate, wherein said nanoparticles comprise a metal sulfide or a metal selenide; (b) subjecting the nanoparticles to spark plasma sintering, thereby producing a sintered product; and (c) removing the sintered product from the substrate as a self-supporting mass. | 08-16-2012 |
Devan Balachari, College Staiton, TX US
Patent application number | Description | Published |
---|---|---|
20120223230 | Monodispersed and Spherical ZnS For Nano-Grain Optical Windows - A method is provided for producing an article which is transparent to infrared radiation. The method includes the steps of (a) disposing a population of nanoparticles on a substrate, wherein the population of spherical nanoparticles has a population variance of less than 10% in at least one parameter selected from the group consisting of diameter and maximum dimension; (b) subjecting the nanoparticles to spark plasma sintering, thereby producing a sintered product; and (c) removing the sintered product from the substrate as a self-supporting mass. | 09-06-2012 |
Devan Naduthambi, Plainsboro, NJ US
Patent application number | Description | Published |
---|---|---|
20110257121 | PURINE NUCLEOSIDE PHOSPHORAMIDATE - Disclosed herein is a compound represented by formula 1 or its hydrate thereof in crystalline or crystal-like form. | 10-20-2011 |
20120202794 | COMPOUNDS - Disclosed herein are compounds useful for treating a viral infection, such as HCV. | 08-09-2012 |
Devan Naduthambi, San Bruno, CA US
Patent application number | Description | Published |
---|---|---|
20150344473 | TANK-BINDING KINASE INHIBITOR COMPOUNDS - Compounds having the following formula (I) and methods of their use and preparation are disclosed: | 12-03-2015 |